Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Details Narrative)

v3.24.1.u1
Stockholders’ Equity (Details Narrative) - USD ($)
 12 Months Ended
Jun. 22, 2022
Jan. 23, 2022
Oct. 19, 2021
Jan. 29, 2021
Dec. 22, 2020
Sep. 25, 2020
Jul. 22, 2020
Dec. 31, 2023
Dec. 31, 2022
Dec. 29, 2023
Sep. 29, 2020
Sep. 30, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of shares granted 1,498,128             893,181 893,181      
Number of additional granted shares issued               120        
Aggregate vested shares value               $ 2,009,657        
Number of unvested shares               15,181        
Unrecognized value of shares               $ 34,157        
Fair value               $ 5,885,772        
Stock repurchase value                 $ 7,536,216      
Repurchase of common stock, shares               519,828        
Repurchase common stock value               $ 7,536,216        
Common stock, shares authorized               100,000,000 100,000,000      
Common stock, par value               $ 0.001 $ 0.001      
Issuance of common stock through partial exercise of underwriter warrants and gross proceeds     $ 562,596                  
Aggregate intrinsic value of outstanding warrants               $ 67,230        
Closing share price                   $ 10.52    
Exercise price $ 7.63                      
Stock granted               $ 9,512,356        
Risk-free interest rate               3.20%        
Voltality rate               106.00%        
Compensation expense               $ 3,626,584        
Vesting term               4 years        
IPO [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of shares issued           1,260,870            
Public offering price           $ 5.75            
Gross proceeds from sale of shares           $ 7,250,002            
Number of shares issued, value           6,207,502            
Underwriting discounts and commissions and offering expenses           $ 1,042,500            
Exercised option to purchase of shares           189,130            
Additional common shares issuable upon conversion of preferred stock                     42,404  
Conversion price per share                     $ 5.75  
Common stock, shares authorized                     100,000,000  
Common stock, par value                     $ 0.001  
Preferred stock, shares authorized                     10,000,000  
Preferred stock, par value                     $ 0.001  
IPO [Member] | Series A Preferred Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Converted shares of preferred stock into common stock                     1,520,937  
IPO [Member] | Series B Preferred Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Converted shares of preferred stock into common stock                     129,267  
IPO [Member] | Series C Preferred Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Converted shares of preferred stock into common stock                     66,575  
IPO [Member] | Series D Preferred Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Converted shares of preferred stock into common stock                     305,990  
Additional common shares issuable upon conversion of preferred stock                     42,404  
Follow On Offering [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of shares issued         660,000              
Public offering price         $ 40.00              
Gross proceeds from sale of shares         $ 26,400,000              
Exercised option to purchase of shares         99,000              
Net proceeds from sale of shares         $ 23,959,000              
Net of underwriting discount commission and offering expenses         $ 2,441,000              
Over-Allotment Option [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Public offering price       $ 40.00                
Gross proceeds from sale of shares       $ 2,800,000                
Underwriting discounts and commissions and offering expenses       $ 252,000                
Exercised option to purchase of shares       70,000                
Net proceeds from sale of shares       $ 2,548,000                
Amended and Restated Certificate of Incorporation [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Reverse stock split             1-for-2.67 reverse stock split          
Maximum [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stock repurchase value   $ 10,000,000                    
Common Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Number of shares granted               908,362 908,362      
Common stock grant vested               0 220,164      
Fair value                 $ 495,369      
Stock repurchase value                 $ 520      
Issuance of common stock through partial exercise of underwriter warrants, shares     80,696                  
Warrant [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Warrants expiration date [1]               Sep. 24, 2025        
Warrant exercise price [1]               $ 7.1875        
Warrant [Member] | IPO [Member] | Aegis Capital Corp [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Public offering price           $ 6.9718            
Warrants to purchase of common stock           100,870            
Sale of shares percentage           8.00%            
Warrants expiration date           Sep. 24, 2025            
Warrant exercise price           $ 7.1875            
Public offering price, percentage           125.00%            
Warrants exercise price, percentage           97.00%            
2019 Equity Incentive Plan [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Common stock capital shares reserved for future issuance                       1,498,128
[1] The warrants are exercisable at any time and from time to time, in whole or in part, during a period commencing March 24, 2021 and expiring September 24, 2025. The exercise price of the warrants is $7.1875 per share or $6.9718 per share if the warrants are exercised for cash within the first six months of the period in which they are exercisable.